Based on the biology of viral infection and clinical disease management, these studies have demonstrated that differences in SARS-CoV-2 severity are associated with the high affinity of SARS-CoV-2 S protein for ACE2, suggesting that populations with higher expression of ACE2 are more susceptible to infection [23,24]. Here, ACE2 is linked to viral infectious disease.